Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Missed Period Pill Study
NCT04940013Phase 4Terminated
- Sponsor
- University of California, San Francisco
- Start
- Oct 2021
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of misoprostol in Menstrual irregularity, sponsored by University of California, San Francisco. Primary endpoints: Interest in missed period pills at 0 weeks and Satisfaction with missed period pills at 4 weeks. Started Oct 2021; status: terminated.
02
Drugs
misoprostol
03
Conditions
Menstrual irregularity
Beyond the preview
Go deeper on NCT04940013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04940013.